EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 77 | +92.5% | 0.00% | – |
| Q2 2021 | $0 | – | 40 | +11.1% | 0.00% | – |
| Q1 2021 | $0 | – | 36 | +5.9% | 0.00% | – |
| Q4 2020 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 34 | +70.0% | 0.00% | – |
| Q2 2020 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 20 | +233.3% | 0.00% | – |
| Q4 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,815,500 | $8,950,000 | 0.30% |
| Sterling Financial Planning, Inc. | 1,171 | $6,000 | 0.01% |
| UBS Group AG | 3,991 | $20,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 468 | $2,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,656 | $62,000 | 0.00% |
| North Star Investment Management Corp. | 20 | $0 | 0.00% |
| MORGAN STANLEY | 466 | $2,000 | 0.00% |